ARTICLE | Company News
CPEX, Serenity deal
August 11, 2008 7:00 AM UTC
The companies disclosed a September 2007 deal to develop and commercialize an undisclosed compound to treat a urology indication. CPEX used its CPE-215 permeation enhancement technology to develop an ...